Your shopping cart is currently empty

Vardenafil-d5hydrochloride is the deuterium-labeled version of Vardenafil hydrochloride. Vardenafil dihydrochloride is a highly selective and orally active phosphodiesterase 5 (PDE5) inhibitor, with an IC50 of 0.7 nM. It displays IC50 values of 180 nM and 11 nM for PDE1 and PDE6, respectively, while for PDE3 and PDE4, the IC50 is greater than 1000 nM. This compound non-competitively inhibits the hydrolysis of cyclic guanosine monophosphate (cGMP), leading to increased cGMP levels. Vardenafil dihydrochloride is useful for studying conditions such as erectile dysfunction, hepatitis, and diabetes.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Vardenafil-d5hydrochloride is the deuterium-labeled version of Vardenafil hydrochloride. Vardenafil dihydrochloride is a highly selective and orally active phosphodiesterase 5 (PDE5) inhibitor, with an IC50 of 0.7 nM. It displays IC50 values of 180 nM and 11 nM for PDE1 and PDE6, respectively, while for PDE3 and PDE4, the IC50 is greater than 1000 nM. This compound non-competitively inhibits the hydrolysis of cyclic guanosine monophosphate (cGMP), leading to increased cGMP levels. Vardenafil dihydrochloride is useful for studying conditions such as erectile dysfunction, hepatitis, and diabetes. |
| In vivo | Vardenafil hydrochloride (IV; 0.03 mg/kg) enhances recovery in rats with cavernous nerve injury. Additionally, vardenafil hydrochloride (IV; 0.17 mg/kg, once daily for 7 days) offers hepatic protection against Con A-induced hepatitis and reduces NF- levels in liver tissue. Furthermore, vardenafil hydrochloride (oral; 10 mg/kg, once daily for 25 weeks) prevents the reduction of tissue cGMP levels and inhibits the increase of 3-NT production in ZDF hearts. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.